STRONGBRIDGE BIOPHARMA PLC's ticker is SBBP and the CUSIP is G85347105. A total of 64 filers reported holding STRONGBRIDGE BIOPHARMA PLC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $184,000 | +13.6% | 66,586 | 0.0% | 0.00% | – |
| Q4 2020 | $162,000 | +37.3% | 66,586 | +18.1% | 0.00% | – |
| Q3 2020 | $118,000 | -44.6% | 56,365 | 0.0% | 0.00% | – |
| Q2 2020 | $213,000 | +99.1% | 56,365 | 0.0% | 0.00% | – |
| Q1 2020 | $107,000 | -7.8% | 56,365 | +1.2% | 0.00% | – |
| Q4 2019 | $116,000 | -12.8% | 55,721 | 0.0% | 0.00% | – |
| Q3 2019 | $133,000 | -23.6% | 55,721 | 0.0% | 0.00% | – |
| Q2 2019 | $174,000 | -54.0% | 55,721 | +30.6% | 0.00% | -100.0% |
| Q1 2018 | $378,000 | +34.0% | 42,671 | +9.6% | 0.00% | 0.0% |
| Q4 2017 | $282,000 | +13.7% | 38,938 | +8.2% | 0.00% | 0.0% |
| Q3 2017 | $248,000 | -10.5% | 36,000 | -7.2% | 0.00% | 0.0% |
| Q2 2017 | $277,000 | – | 38,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 6,612,065 | $15,803,000 | 17.82% |
| Prosight Management, LP | 2,515,072 | $6,011,000 | 3.33% |
| 22NW, LP | 804,410 | $1,923,000 | 2.54% |
| Broadfin Capital, LLC | 2,578,003 | $6,161,000 | 1.14% |
| NEA Management Company, LLC | 4,141,308 | $9,898,000 | 0.82% |
| Opaleye Management Inc. | 490,000 | $1,171,000 | 0.42% |
| PA Capital LLC | 152,977 | $366,000 | 0.36% |
| 683 Capital Management, LLC | 923,700 | $2,208,000 | 0.25% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 414,982 | $992,000 | 0.14% |
| Hudson Bay Capital Management LP | 1,475,000 | $3,525,000 | 0.10% |